http://www.legislation.gov.uk/uksi/2004/1031/introduction/2022-07-01
The Medicines for Human Use (Clinical Trials) Regulations 2004
text
text/xml
en
MEDICINES
Statute Law Database
2024-06-19
Expert Participation
2022-07-01
These Regulations implement Directive 2001/20/EC on the approximation of laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use (“the Directive”).
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 2(1)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 3(7)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 2(1)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 3(9)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 13(4)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 7(5)(i)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 13(4)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 7(5)(ii)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 36(2)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 17
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 43(2)-(2F)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 18
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 45(1)(f)(i)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 20
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 3 Pt. 2
para. 7
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 24(3)(c)(i)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 3 Pt. 2
para. 7
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 24(3)(c)(ii)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 3 Pt. 2
para. 8(1)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 24(3)(d)(i)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 3 Pt. 2
para. 8(2)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 24(3)(d)(ii)(aa)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 3 Pt. 2
para. 8(2)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 24(3)(d)(ii)(bb)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 3 Pt. 2
para. 8(2)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 24(3)(d)(ii)(cc)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 3 Pt. 2
para. 8(2)(a)
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 24(3)(d)(ii)(dd)
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
Sch. 7
Pt. 1
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
reg. 25
reg. 1
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 2(1)
The Anaesthesia Associates and Physician Associates Order 2024
Sch. 5
para. 11(a)
art. 1(3)
The Medicines for Human Use (Clinical Trials) Regulations 2004
reg. 2(1)
The Anaesthesia Associates and Physician Associates Order 2024
Sch. 5
para. 11(b)
art. 1(3)
2004 No. 1031
MEDICINES
The Medicines for Human Use (Clinical Trials) Regulations 2004
Made
Laid before Parliament
Coming into force
The Secretary of State, being a Minister designated F1 for the purposes of section 2(2) of the European Communities Act 1972 F2 in relation to medicinal products, in exercise of the powers conferred by the said section 2(2), and of all other powers enabling him in that behalf, hereby makes the following Regulations:
Annotations:
Amendments (Textual)
F2
S.I. 1972/1811.